Pancreatic Cancer Research

ResearcherNingbo UniversityActive in the last 2 years

Luoluo Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5021484514. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Curcumin suppresses pancreatic cancer progression and glycolysis by modulating the circ_0001535/miR-126-5p/HIPK2 axis. Co-author DOI 10.1080/1061186x.2026.2646184↗
  2. Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p. Co-author DOI 10.1007/s12033-024-01091-z↗
  3. Circ_103809 Aggravates the Malignant Phenotype of Pancreatic Cancer Through Modulating miR-197-3p/TSPAN3 Axis. Co-author DOI 10.1007/s12033-023-00874-0↗
  4. Exosome-transmitted hsa_circ_0012634 suppresses pancreatic ductal adenocarcinoma progression through regulating miR-147b/HIPK2 axis. Co-author DOI 10.1080/15384047.2023.2218514↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiang Wu · 4 shared papers, 2023–2026 · strength 1.03
  2. Xinhua Zhou · 3 shared papers, 2023–2026 · strength 0.81
  3. Xinhua Zhou · 1 shared paper, 2025 · strength 0.22
  4. Dongjian Ying · 1 shared paper, 2025 · strength 0.22
  5. Yeting Lu · 1 shared paper, 2025 · strength 0.22
  6. Hong Li · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.